Home/Filings/4/0001104659-23-095369
4//SEC Filing

Granfield Christine 4

Accession 0001104659-23-095369

CIK 0001509745other

Filed

Aug 24, 8:00 PM ET

Accepted

Aug 25, 4:30 PM ET

Size

5.9 KB

Accession

0001104659-23-095369

Insider Transaction Report

Form 4
Period: 2023-08-23
Granfield Christine
VP, Head of Reg Affairs/Qual
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2023-08-23+70,00070,000 total
    Exercise: $2.21Exp: 2033-08-23Common Stock (70,000 underlying)
Footnotes (1)
  • [F1]The Option was granted pursuant to Leap's 2022 Equity Incentive Plan, as amended. By its terms, the Option shall vest and become exercisable for the shares underlying the Option in a series of 36 equal monthly installments for so long as the reporting person continues to be employed by or provides service to the Company, with the first of such monthly installments vesting on September 23, 2023 and an additional of such monthly installments vesting on the 23rd day of each calendar month thereafter.

Issuer

LEAP THERAPEUTICS, INC.

CIK 0001509745

Entity typeother

Related Parties

1
  • filerCIK 0001822190

Filing Metadata

Form type
4
Filed
Aug 24, 8:00 PM ET
Accepted
Aug 25, 4:30 PM ET
Size
5.9 KB